InterAx Biotech

Private

SchlierenHealthcare & Life Scienceshttps://interaxbiotech.com/

Last Round

Grant

Nov 10, 2023

Total Funding Raised

$3.79M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

InterAx Biotech is a biotechnology company that has developed a drug discovery platform integrating mathematical modeling, artificial intelligence, and experimental methods to design and select novel drugs targeting G protein-coupled receptors (GPCRs).

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

GPCR drug discoveryG-Protein-Coupled ReceptorsGPCRsAI drug discoverydrug discovery platformtechbiosystems biologycellular signalingin silico drug discoverybiosensorsdrug licensingGLP-1R agonistweight loss drugsimmuno-oncologydrug screening

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

InterAx Biotech Comparables

Compare InterAx Biotech with similar companies based on industry and business-model similarity.

InterAx Biotech comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Confo Therapeutics	81%
Abalone Bio	78%
Octant	78%

View all Comparables

InterAx Biotech Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Grant	Nov 10, 2023
Series A	Jan 15, 2019
Seed	Dec 6, 2016

View all Funding Rounds

Key People

Founding team and executive leadership

Luca Zenone

Co-Founder, CFO & COO

Founding Team

Andrew Roberts

Chief Executive Officer

Executive Team

Aurélien Rizk

Co-Founder & CSO, Co-founder & CEO

Founding Team

Yaroslav Nikolaev

CTO, Head Of Computational Science, Head Of Computational Science Acting CTO

Executive Team

View all key people

InterAx Biotech Investors

Notable investors and investment history

InterAx Biotech investors
Investor	Rounds
European Innovation Council Fund	Grant
Verve Ventures	Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Apr 21, 2026
Monthly visitors grew 65% MoM.
May 4, 2025
Monthly visitors increased 600% MoM.

View all signals

InterAx Biotech Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

InterAx Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about InterAx Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersSchlieren

Employee Range15

Year Founded2016

Last FundingNov 10, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.